The search for cost-effective treatment of chronic hepatitis B.
Smith
Vanessa E
VE
Kaiser Permanente, Center for Health Research/Southeast, Cumberland Medical Office, 2525 Cumberland Pkwy., Atlanta, GA 30339, USA. vanessa.c.smith@kp.org
Bruno
Christine J
CJ
D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006513:Hepatitis B e Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000187:drug effects / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D014481:United States
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D019259:Lamivudine; C413685:entecavir; D006147:Guanine